Due to health issues, this site is no longer maintained and will be shut down shortly.

DRTSW Alpha Tau Medical Ltd. - Warrant

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers. The company was founded in 2015 and is headquartered in Jerusalem, Israel.  This security was issued by Alpha Tau Medical Ltd. - Class A, whose common stock symbol is DRTS.

$0.28  -0.00 (-0.04%)
As of 03/22/2023 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Warrants
Category3:  Operating Companies
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  03/07/2022
Outstanding shares:  23,410,762
Average volume:  2,607
Market cap:   $194,267,484
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy